Filing Details

Accession Number:
0001209191-18-062934
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-17 16:19:14
Reporting Period:
2018-12-17
Accepted Time:
2018-12-17 16:19:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1169245 Phasebio Pharmaceuticals Inc PHAS Pharmaceutical Preparations (2834) 030375697
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1379222 J Nancy Hutson C/O Phasebio Pharmaceuticals, Inc.
1 Great Valley Parkway, Suite 30
Malvern PA 19355
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-17 1,000 $4.46 1,000 No 4 P Indirect Held in an individual retirement account for the benefit of the reporting person
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held in an individual retirement account for the benefit of the reporting person